Eupraxia Pharmaceuticals Announces Positive Data From Fifth Cohort Of RESOLVE Phase 1B/2A Trial Of EP-104GI For Treatment Of Eosinophilic Esophagitis
One of three patients in Cohort 5 achieved complete histological remission at 12 weeks. <li /> Consistent improve ...
The Firsthand Results Of A Nanofat Treatment Using Stem Cells And PRP
PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...
Low-cost method removes micro- and nanoplastics from water
Researchers at the University of São Paulo (USP) in Brazil have developed a novel nanotechnology-based solution for the ...
clinicaltrialsarena14h
Cerevance reports results from trial of CVN293 for neurodegenerative conditions
Cerevance has announced positive outcomes from its Phase I trial of CVN293, a drug candidate designed to treat ...
Blood vessel-like coating could make medical devices safer for patients
University of B.C. researchers have developed a coating that could make medical devices safer for millions of patients, ...